fda warning bpc-157 compounding pharmacies Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Exciting news for peptides coming

Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT

SKU: 50075417003 · From centoria.fr